Clinical Review State of the Art Review Clostridioides difficile: diagnosis and treatments BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4609 (Published 20 August 2019) Cite this as: BMJ 2019;366:l4609 Article Related content Metrics Responses Peer review Related articles No related articles found. See more GP efforts to cut antibiotic use failed to curb spread of drug resistant E coli, evaluation finds BMJ August 05, 2021, 374 n1953; DOI: https://doi.org/10.1136/bmj.n1953 Check covid status when planning emergency bowel surgery, doctors are told BMJ March 11, 2021, 372 n695; DOI: https://doi.org/10.1136/bmj.n695 Capsule endoscopies will be trialled in England BMJ March 11, 2021, 372 n692; DOI: https://doi.org/10.1136/bmj.n692 All ranitidine should be discarded, says US drug agency BMJ April 06, 2020, 369 m1390; DOI: https://doi.org/10.1136/bmj.m1390 Ranitidine: doctors should switch patients to alternative, says health department BMJ October 17, 2019, 367 l6087; DOI: https://doi.org/10.1136/bmj.l6087 Cited by... A putative erm gene is present in {Delta}ermB Clostridioides difficile isolates showing high levels of resistance to clindamycinAbstract Fulltext PDF An RNA-centric global view of Clostridioides difficile reveals broad activity of Hfq in a clinically important gram-positive bacteriumAbstract Fulltext PDF In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficileAbstract Fulltext PDF Discordant Clostridioides difficile diagnostic assay and treatment practice: a cross-sectional study in a tertiary care hospital, Geneva, SwitzerlandAbstract Fulltext PDF Management of difficult-to-treat Clostridioides difficile in a patient with chronic osteomyelitisAbstract Fulltext PDF
